Others

Torrent Pharmaceuticals Ltd. - Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations 2015, (Listing Regulations)

| Updated on November 03, 2018 Published on November 03, 2018

We would like to inform that the Board has at its meeting held today approved, inter-alia, the following:

1) Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with the limited review report of the Company for the quarter and half year ended on 30th September, 2018. The said financial results are enclosed herewith.

In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Unaudited Consolidated Financial Results for the quarter and half year ended on 30th September, 2018. Both Standalone and Consolidated Financial Results will be available at Companys website www.torrentpharma.com.

2) A Press Release on Financial Results which is being submitted to the media is also enclosed herewith.

The above is for your information and record.

Pdf Link: Torrent Pharmaceuticals Ltd. - Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations 2015, (Listing Regulations)

Source : BSE - www.bseindia.com

Published on November 03, 2018
This article is closed for comments.
Please Email the Editor